1Department of Surgery, University of Michigan Medical Center, Ann Arbor.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Surgical removal of massively enlarged spleens (≥1,500g) in patients with myeloproliferative disorders does not increase morbidity or mortality, except for increased blood loss in non-Hodgkin
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: